JP2021523126A5 - - Google Patents
Info
- Publication number
- JP2021523126A5 JP2021523126A5 JP2020561795A JP2020561795A JP2021523126A5 JP 2021523126 A5 JP2021523126 A5 JP 2021523126A5 JP 2020561795 A JP2020561795 A JP 2020561795A JP 2020561795 A JP2020561795 A JP 2020561795A JP 2021523126 A5 JP2021523126 A5 JP 2021523126A5
- Authority
- JP
- Japan
- Prior art keywords
- months
- composition according
- accumulated
- pathological tau
- subject
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666459P | 2018-05-03 | 2018-05-03 | |
| US62/666,459 | 2018-05-03 | ||
| PCT/US2019/030184 WO2019213245A1 (en) | 2018-05-03 | 2019-05-01 | Methods for reducing accumulated pathologic tau protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523126A JP2021523126A (ja) | 2021-09-02 |
| JP2021523126A5 true JP2021523126A5 (https=) | 2022-05-10 |
| JPWO2019213245A5 JPWO2019213245A5 (https=) | 2022-05-10 |
Family
ID=66530499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561795A Pending JP2021523126A (ja) | 2018-05-03 | 2019-05-01 | 蓄積した病理学的Ｔａｕタンパク質を低減する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210137861A1 (https=) |
| EP (1) | EP3787750A1 (https=) |
| JP (1) | JP2021523126A (https=) |
| WO (1) | WO2019213245A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12076332B2 (en) | 2018-04-27 | 2024-09-03 | The Regents Of The University Of California | Treatment of lysosomal storage disorders |
| EP3784795A4 (en) | 2018-04-27 | 2022-01-19 | The Regents Of The University Of California | INHIBITION OF LIPOFUSCIN AGGREGATION BY MOLECULAR TWEEZERS |
| CN115151250A (zh) * | 2020-02-24 | 2022-10-04 | 欧博拉托股份有限公司 | 用于治疗癌症或肿瘤的组合物和方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0737208T3 (da) * | 1993-12-21 | 2006-11-27 | Innogenetics Nv | Monoklonale antistoffer, der er specifikke for PHF-tau, hybridomaer, der secernerer dem, og antigen-genkendelse for disse antistoffer og deres anvendelsesmuligheder |
| US5488145A (en) | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| AU2003291358A1 (en) * | 2002-11-07 | 2004-06-03 | Molecular Geriatrics Corporation | Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| CA2772097C (en) * | 2009-08-24 | 2019-04-30 | Hough Ear Institute | Methods for treating acute acoustic trauma |
| ES2893825T3 (es) * | 2011-02-04 | 2022-02-10 | Hough Ear Inst | Métodos de tratamiento de lesiones cerebrales |
| JP6126531B2 (ja) * | 2011-10-03 | 2017-05-10 | 国立研究開発法人国立長寿医療研究センター | タウ凝集阻害剤 |
| US20180256756A1 (en) * | 2015-09-18 | 2018-09-13 | Oklahoma Medical Research Foundation | Method of transporting an agent across blood-brain, blood-cochlear or blood-cerebrospinal fluid barrier |
| CN110248650A (zh) * | 2016-10-31 | 2019-09-17 | 霍夫耳科研究所 | 用于增强突触发生和神经突发生的方法 |
-
2019
- 2019-05-01 US US17/052,093 patent/US20210137861A1/en active Pending
- 2019-05-01 WO PCT/US2019/030184 patent/WO2019213245A1/en not_active Ceased
- 2019-05-01 JP JP2020561795A patent/JP2021523126A/ja active Pending
- 2019-05-01 EP EP19723991.6A patent/EP3787750A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523126A5 (https=) | ||
| Roberts et al. | Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis | |
| Molinuevo et al. | Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias | |
| JP2019537582A5 (https=) | ||
| Bates et al. | Ototoxicity induced by gentamicin and furosemide | |
| Kornblut et al. | Ear disease in patients with Wegener's granulomatosis | |
| JP2011527339A5 (https=) | ||
| JP2025060686A5 (https=) | ||
| JP2019524834A5 (https=) | ||
| JP2018514510A5 (https=) | ||
| JP2015523346A5 (https=) | ||
| WO2008021970A3 (en) | Treatment of motor neuron disease, including certain neurological disorders, motor neuropathies and chronic inflammatory diseases | |
| JP2021529829A5 (https=) | ||
| JP2018505218A5 (https=) | ||
| ES2534553T3 (es) | Formulaciones y métodos para tratar la amiloidosis | |
| US11690830B2 (en) | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | |
| JP2018512451A5 (https=) | ||
| JP2020504154A5 (https=) | ||
| JPWO2019213245A5 (https=) | ||
| JP2020527138A5 (https=) | ||
| JP2021522241A5 (https=) | ||
| CN117651556A (zh) | 与cyp3a抑制剂和阿扎胞苷联合治疗骨髓增生异常综合征的维奈托克给药方案 | |
| CN102716123A (zh) | 一种用于治疗IgA肾病复方制剂 | |
| Thoene et al. | Pharmacotherapy of otitis media | |
| JP2021522205A (ja) | 敗血症および敗血症性ショックの治療 |